Patents by Inventor Gi Duk BAE

Gi Duk BAE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9758767
    Abstract: Provided is a novel bacteriophage ?CJ22 (KCCM11364P). In addition, provided is an antibacterial composition containing the bacteriophage ?CJ22 (KCCM11364P) as an active ingredient. Further, provided is a method of preventing and/or treating infectious diseases caused by Clostridium perfringens in animals except for humans by using the bacteriophage ?CJ22 (KCCM11364P) or an antibacterial composition containing the bacteriophage ?CJ22 (KCCM11364P) as an active ingredient.
    Type: Grant
    Filed: February 26, 2014
    Date of Patent: September 12, 2017
    Assignee: CJ CHEILJEDANG CORPORATION
    Inventors: Bo Kyung Son, Gi Duk Bae, Jae Won Kim
  • Patent number: 9745555
    Abstract: Provided is a novel bacteriophage ?CJ21 (KCCM11363P). In addition, the present invention relates to an antibacterial composition including the bacteriophage ?CJ21 (KCCM11363P) as an active ingredient. Further, provided is a method of preventing and/or treating infectious diseases by Clostridium perfringens in animals except for humans using the bacteriophage ?CJ21 (KCCM11363P) or the antibacterial composition containing the bacteriophage ?CJ21 (KCCM11363P) as an active ingredient.
    Type: Grant
    Filed: February 26, 2014
    Date of Patent: August 29, 2017
    Assignee: CJ CHEILJEDANG CORPORATION
    Inventors: Bo Kyung Son, Gi Duk Bae, Jae Won Kim
  • Publication number: 20170189459
    Abstract: The present invention relates to a novel bacteriophage ?CJ24 (KCCM11462P) and a composition comprising the same as an active component. In addition, the present invention relates to a method for preventing and/or treating infectious diseases caused by avian pathogenic E. coli of birds by using the bacteriophage ?CJ24 (KCCM11462P) or the composition.
    Type: Application
    Filed: April 14, 2015
    Publication date: July 6, 2017
    Applicant: CJ CHEILJEDANG CORPORATION
    Inventors: Eun Mi SHIN, Gi Duk BAE, Jae Won KIM
  • Publication number: 20170189460
    Abstract: The present invention relates to a novel bacteriophage ?CJ26 (KCCM11464P) and a composition comprising the same as an active ingredient. In addition, the present invention relates to a method for preventing and/or treating infectious diseases caused by Salmonella by using the bacteriophage ?CJ26 (KCCM11464P) or the composition.
    Type: Application
    Filed: April 14, 2015
    Publication date: July 6, 2017
    Applicant: CJ CHEILJEDANG CORPORATION
    Inventors: Eun Mi SHIN, Bo Kyung SON, Gi Duk BAE, Jae Won KIM
  • Patent number: 9657277
    Abstract: Provided is a novel bacteriophage ?CJ19 (KCCM11361P). In addition, the present invention relates to an antibacterial composition including the bacteriophage ?CJ19 (KCCM11361P) as an active ingredient. Further, the present invention is a method of preventing and/or treating infectious diseases by enterotoxigenic Escherichia coli in animals except for humans using the bacteriophage ?CJ19 (KCCM11361P) or the antibacterial composition containing the bacteriophage ?CJ19 (KCCM11361P) as an active ingredient.
    Type: Grant
    Filed: February 24, 2014
    Date of Patent: May 23, 2017
    Assignee: CJ CHEILJEDANG CORPORATION
    Inventors: Eun Mi Shin, Gi Duk Bae, Jae Won Kim
  • Publication number: 20170035817
    Abstract: The present invention relates to a novel bacteriophage ?CJ27 (KCCM11465P) and a composition containing the same as an active ingredient. Further, the present invention relates to a method for preventing and/or treating infective diseases caused by enterotoxic Escherichia coli (ETEC) of non-human animals using the ?CJ27 (KCCM11465P) and the composition.
    Type: Application
    Filed: March 13, 2015
    Publication date: February 9, 2017
    Applicant: CJ CHEILJEDANG CORPORATION
    Inventors: Eun Mi SHIN, Gi Duk BAE, Jae Won KIM
  • Publication number: 20170037380
    Abstract: The present invention relates to a novel bacteriophage ?CJ28 (KCCM11466P) and a composition containing the same as an active ingredient. Further, the present invention relates to a method for preventing and/or treating infective diseases caused by enterotoxic Escherichia coli (ETEC) of animals excluding humans by using the composition.
    Type: Application
    Filed: March 13, 2015
    Publication date: February 9, 2017
    Applicant: CJ CHEILJEDANG CORPORATION
    Inventors: Eun Mi SHIN, Gi Duk BAE, Jae Won KIM
  • Publication number: 20170037382
    Abstract: The present invention relates to a novel bacteriophage ?CJ25 (KCCM11463P) and a composition comprising the same as an active ingredient. In addition, the present invention relates to a method for preventing and/or treating infectious diseases caused by avian pathogenic Escherichia coli (APEC) of birds by using the bacteriophage ?CJ25 (KCCM11463P) or the composition.
    Type: Application
    Filed: April 14, 2015
    Publication date: February 9, 2017
    Applicant: CJ CHEILJEDANG CORPORATION
    Inventors: Eun Mi SHIN, Gi Duk BAE, Jae Won KIM
  • Publication number: 20160083695
    Abstract: Provided is a novel bacteriophage ?CJ23 (KCCM11365P). In addition, the present invention relates to an antibacterial composition including the bacteriophage ?CJ23 (KCCM11365P) as an active ingredient. Further, provided is a method of preventing and/or treating infectious diseases by avian pathogenic Escherichia coli (APEC) in birds using the bacteriophage ?CJ23(KCCM11365P) or the antibacterial composition containing the bacteriophage ?CJ23(KCCM11365P) as an active ingredient.
    Type: Application
    Filed: February 25, 2014
    Publication date: March 24, 2016
    Applicant: CJ CHEILJEDANG CORPORATION
    Inventors: Hyo Seel SEO, Eun Mi SHIN, Gi Duk BAE, Jae Won KIM
  • Publication number: 20160083697
    Abstract: Provided is a novel bacteriophage ?CJ20 (KCCM11362P). In addition, the present invention relates to an antibacterial composition including the bacteriophage ?CJ20 (KCCM11362P) as an active ingredient. Further, the present invention is a method of preventing and/or treating infectious diseases by enterotoxigenic Escherichia coli in animals except for humans using the bacteriophage ?CJ20 (KCCM11362P) or the antibacterial composition containing the bacteriophage ?CJ20 (KCCM11362P) as an active ingredient.
    Type: Application
    Filed: February 24, 2014
    Publication date: March 24, 2016
    Inventors: Eun Mi SHIN, Gi Duk BAE, Jae Won KIM
  • Publication number: 20160083696
    Abstract: Provided is a novel bacteriophage ?CJ20 (KCCM11362P). In addition, the present invention relates to an antibacterial composition including the bacteriophage ?CJ20 (KCCM11362P) as an active ingredient. Further, the present invention is a method of preventing and/or treating infectious diseases by enterotoxigenic Escherichia coli in animals except for humans using the bacteriophage ?CJ20 (KCCM11362P) or the antibacterial composition containing the bacteriophage ?CJ20 (KCCM11362P) as an active ingredient.
    Type: Application
    Filed: February 24, 2014
    Publication date: March 24, 2016
    Applicant: CJ CHEILJEDANG CORPORATION
    Inventors: Eun Mi SHIN, Gi Duk BAE, Jae Won KIM
  • Publication number: 20160076003
    Abstract: Provided is a novel bacteriophage ?CJ22 (KCCM11364P). In addition, provided is an antibacterial composition containing the bacteriophage ?CJ22 (KCCM11364P) as an active ingredient. Further, provided is a method of preventing and/or treating infectious diseases caused by Clostridium perfringens in animals except for humans by using the bacteriophage ?CJ22 (KCCM11364P) or an antibacterial composition containing the bacteriophage ?CJ22 (KCCM11364P) as an active ingredient.
    Type: Application
    Filed: February 26, 2014
    Publication date: March 17, 2016
    Inventors: Bo Kyung SON, Gi Duk BAE, Jae Won KIM
  • Publication number: 20160076004
    Abstract: Provided is a novel bacteriophage ?CJ21 (KCCM11363P). In addition, the present invention relates to an antibacterial composition including the bacteriophage ?CJ21 (KCCM11363P) as an active ingredient. Further, provided is a method of preventing and/or treating infectious diseases by Clostridium perfringens in animals except for humans using the bacteriophage ?CJ21 (KCCM11363P) or the antibacterial composition containing the bacteriophage ?CJ21 (KCCM11363P) as an active ingredient.
    Type: Application
    Filed: February 26, 2014
    Publication date: March 17, 2016
    Inventors: Bo Kyung SON, Gi Duk BAE, Jae Won KIM